Michael A Sobieski
Overview
Explore the profile of Michael A Sobieski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Z, Jena S, Giridharan G, Sobieski M, Koenig S, Slaughter M, et al.
Med Biol Eng Comput
. 2018 Nov;
57(4):807-818.
PMID: 30406881
Modulation of pump speed has been proposed and implemented clinically to improve vascular pulsatility in continuous flow ventricular assist device patient. The flow dynamics of the HVAD with a promising...
2.
Mondal N, Li T, Chen Z, Chen H, Sorensen E, Pham S, et al.
Mol Cell Biochem
. 2017 Aug;
433(1-2):139.
PMID: 28770469
No abstract available.
3.
Wang Y, Koenig S, Sobieski M, Slaughter M, Giridharan G
Cardiovasc Eng Technol
. 2017 Jul;
8(4):439-452.
PMID: 28707188
Mechanical circulatory support (MCS) devices have become a standard therapy for heart failure (HF) patients. MCS device designs may differ by level of support, inflow and/or outflow cannulation sites, and...
4.
Mondal N, Li T, Chen Z, Chen H, Sorensen E, Pham S, et al.
Mol Cell Biochem
. 2017 Mar;
433(1-2):125-137.
PMID: 28343311
Non-surgical bleeding (NSB) is the most common clinical complication in heart failure (HF) patients supported by continuous-flow left ventricular assist devices (CF-LVADs). In this study, oxidative stress and alteration of...
5.
Soucy K, Bartoli C, Phillips D, Giridharan G, Sobieski M, Wead W, et al.
Ann Biomed Eng
. 2017 Feb;
45(6):1475-1486.
PMID: 28168379
Continuous-flow left ventricular assist devices (CF LVADs) are rotary blood pumps that improve mean blood flow, but with potential limitations of non-physiological ventricular volume unloading and diminished vascular pulsatility. In...
6.
Gallo M, Trivedi J, Sobieski M, Massey T, Cheng A, Slaughter M
ASAIO J
. 2016 Dec;
63(3):364-366.
PMID: 28009711
Implantable continuous-flow left ventricular assist devices (LVADs) have improved the survival of end-stage heart failure patients. Recent studies have shown an increased occurrence of device replacement in the axial flow...
7.
Carnahan S, Koenig S, Sobieski M, Schumer E, Monreal G, Wang Y, et al.
ASAIO J
. 2016 Dec;
63(2):134-138.
PMID: 27984317
Counterpulsation devices (CPDs) require an accurate, reliable electrocardiogram (ECG) waveform for triggering inflation and deflation. Surface electrodes are for short-term use, and transvenous/epicardial leads require invasive implant procedure. A subcutaneous...
8.
Mondal N, Sobieski M, Pham S, Griffith B, Koenig S, Slaughter M, et al.
ASAIO J
. 2016 Dec;
63(2):128-133.
PMID: 27922883
The objective of this study was to investigate the changes in oxidative stress (OS) and circulating regulatory T cells (Tregs) of the immune system in patients supported by continuous-flow ventricular...
9.
Ising M, Sobieski M, Slaughter M, Koenig S, Giridharan G
ASAIO J
. 2015 Jun;
61(5):526-32.
PMID: 26102173
Continuous flow (CF) left ventricular assist devices (LVAD) diminish vascular pressure pulsatility, which may be associated with clinically reported adverse events including gastrointestinal bleeding, aortic valve insufficiency, and hemorrhagic stroke....
10.
Schumer E, Zoeller K, Linsky P, Monreal G, Choi Y, Giridharan G, et al.
Ann Thorac Surg
. 2015 Apr;
99(6):1961-7.
PMID: 25921254
Background: Ex vivo lung perfusion (EVLP) has the potential to increase the donor pool for lung transplantation by facilitating resuscitation and extended evaluation of marginal organs. Current EVLP methodology employs...